Changes in blood coagulation and fibrinolysis in women receiving oral contraceptives. Comparison between treated and untreated women in a longitudinal study.
D001777:Blood Coagulation / Q000187:drug effects*; D001780:Blood Coagulation Tests; D002715:Chlormadinone Acetate / Q000009:adverse effects; D003276:Contraceptives, Oral / Q000009:adverse effects*; D004997:Ethinyl Estradiol / Q000009:adverse effects; D005040:Ethynodiol Diacetate / Q000009:adverse effects; D005260:Female; D005342:Fibrinolysis / Q000187:drug effects*; D006801:Humans; D008234:Lynestrenol / Q000009:adverse effects; D008525:Medroxyprogesterone / Q000009:adverse effects; D008535:Megestrol / Q000009:adverse effects; D008656:Mestranol / Q000009:adverse effects; D009640:Norethindrone / Q000009:adverse effects; D011247:Pregnancy; D011278:Pregnanes / Q000009:adverse effects; D011372:Progestins / Q000009:adverse effects; D013923:Thromboembolism / Q000139:chemically induced
D003276:Contraceptives, Oral; D011278:Pregnanes; D011372:Progestins; D002715:Chlormadinone Acetate; D004997:Ethinyl Estradiol; D005040:Ethynodiol Diacetate; D008656:Mestranol; D008535:Megestrol; D008525:Medroxyprogesterone; D008234:Lynestrenol; D009640:Norethindrone